Bank OZK Sells 1,530 Shares of JPMorgan Chase & Co. (NYSE:JPM)

Bank OZK trimmed its holdings in shares of JPMorgan Chase & Co. (NYSE:JPM - Free Report) by 7.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,805 shares of the financial services provider's stock after selling 1,530 shares during the quarter. JPMorgan Chase & Co. makes up approximately 2.0% of Bank OZK's investment portfolio, making the stock its 7th largest position. Bank OZK's holdings in JPMorgan Chase & Co. were worth $4,747,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. lifted its position in shares of JPMorgan Chase & Co. by 7.7% in the third quarter. JPMorgan Chase & Co. now owns 4,450,775 shares of the financial services provider's stock valued at $938,491,000 after acquiring an additional 319,730 shares in the last quarter. Kingsview Wealth Management LLC raised its stake in JPMorgan Chase & Co. by 2.5% in the 3rd quarter. Kingsview Wealth Management LLC now owns 118,095 shares of the financial services provider's stock valued at $24,902,000 after purchasing an additional 2,839 shares during the last quarter. Brighton Jones LLC lifted its holdings in JPMorgan Chase & Co. by 11.0% in the 4th quarter. Brighton Jones LLC now owns 48,732 shares of the financial services provider's stock valued at $11,682,000 after purchasing an additional 4,841 shares in the last quarter. Zions Bancorporation N.A. boosted its stake in JPMorgan Chase & Co. by 2.5% during the 3rd quarter. Zions Bancorporation N.A. now owns 11,157 shares of the financial services provider's stock worth $2,353,000 after purchasing an additional 267 shares during the last quarter. Finally, Algert Global LLC acquired a new stake in JPMorgan Chase & Co. during the 3rd quarter worth $3,017,000. Institutional investors and hedge funds own 71.55% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

JPM has been the subject of a number of recent research reports. Citigroup increased their target price on shares of JPMorgan Chase & Co. from $215.00 to $250.00 and gave the company a "neutral" rating in a research report on Tuesday, November 19th. Truist Financial increased their price objective on shares of JPMorgan Chase & Co. from $260.00 to $268.00 and gave the company a "hold" rating in a report on Thursday, January 16th. UBS Group boosted their target price on JPMorgan Chase & Co. from $276.00 to $287.00 and gave the stock a "buy" rating in a report on Thursday, January 16th. Robert W. Baird upgraded JPMorgan Chase & Co. from an "underperform" rating to a "neutral" rating and upped their price target for the company from $215.00 to $220.00 in a research report on Friday. Finally, Wells Fargo & Company lifted their price objective on JPMorgan Chase & Co. from $240.00 to $270.00 and gave the stock an "overweight" rating in a research report on Friday, November 15th. Ten research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $252.89.

Insiders Place Their Bets

In other news, insider Robin Leopold sold 1,250 shares of the company's stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $270.09, for a total transaction of $337,612.50. Following the sale, the insider now owns 50,377 shares of the company's stock, valued at approximately $13,606,323.93. This represents a 2.42 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Troy L. Rohrbaugh sold 37,500 shares of JPMorgan Chase & Co. stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $269.84, for a total value of $10,119,000.00. Following the completion of the transaction, the chief executive officer now owns 158,381 shares of the company's stock, valued at approximately $42,737,529.04. This trade represents a 19.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 46,326 shares of company stock worth $12,448,445 in the last ninety days. 0.79% of the stock is owned by corporate insiders.

JPMorgan Chase & Co. Trading Down 1.3 %

Shares of JPM stock traded down $2.96 during trading hours on Tuesday, hitting $229.26. The company had a trading volume of 18,128,300 shares, compared to its average volume of 8,784,165. The company has a debt-to-equity ratio of 1.24, a current ratio of 0.88 and a quick ratio of 0.89. The stock has a market capitalization of $641.03 billion, a PE ratio of 11.61, a price-to-earnings-growth ratio of 2.83 and a beta of 1.10. The company's fifty day moving average is $259.26 and its 200 day moving average is $238.70. JPMorgan Chase & Co. has a fifty-two week low of $179.20 and a fifty-two week high of $280.25.

JPMorgan Chase & Co. (NYSE:JPM - Get Free Report) last posted its earnings results on Wednesday, January 15th. The financial services provider reported $4.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.03 by $0.78. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. The firm had revenue of $42.77 billion for the quarter, compared to analyst estimates of $41.90 billion. During the same quarter in the prior year, the company earned $3.04 EPS. JPMorgan Chase & Co.'s revenue was up 10.9% on a year-over-year basis. Research analysts expect that JPMorgan Chase & Co. will post 18.1 earnings per share for the current fiscal year.

About JPMorgan Chase & Co.

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.